Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
8.33
+0.13 (1.59%)
Oct 14, 2025, 12:04 PM EDT - Market open
Lexeo Therapeutics Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$16.71
Upside
+100.60%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $15 | Strong Buy | Maintains | $9 → $15 | +80.07% | Oct 7, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $15 → $17 | Strong Buy | Maintains | $15 → $17 | +104.08% | Oct 7, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $9 → $20 | Buy | Maintains | $9 → $20 | +140.10% | Oct 7, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $15 → $9 | Buy | Maintains | $15 → $9 | +8.04% | Aug 15, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 → $15 | Strong Buy | Maintains | $20 → $15 | +80.07% | Aug 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $9 | Strong Buy | Maintains | $15 → $9 | +8.04% | Aug 15, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $20 | Buy | Initiates | $20 | +140.10% | Jul 31, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $16 → $10 | Buy | Maintains | $16 → $10 | +20.05% | May 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $23 → $15 | Strong Buy | Maintains | $23 → $15 | +80.07% | May 16, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $22 → $20 | Strong Buy | Maintains | $22 → $20 | +140.10% | May 13, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $18 → $16 | Buy | Maintains | $18 → $16 | +92.08% | May 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +176.11% | Apr 8, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $25 → $22 | Strong Buy | Maintains | $25 → $22 | +164.11% | Apr 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +176.11% | Mar 26, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +200.12% | Mar 25, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $24 → $20 | Buy | Maintains | $24 → $20 | +140.10% | Mar 25, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.